COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Smart Phone Application in Increasing Physical Activity in Breast Cancer Survivors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03054025
Recruitment Status : Terminated (funding discontinued)
First Posted : February 15, 2017
Last Update Posted : November 1, 2019
Information provided by (Responsible Party):
Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )

Brief Summary:
This pilot clinical trial studies how well a smart phone application works in increasing physical activity in breast cancer survivors. A smart phone application that increases physical activity may help reduce the likelihood of cancer coming back in breast cancer survivors.

Condition or disease Intervention/treatment Phase
Breast Cancer Device: Smart Phone Monitoring Device Not Applicable

Detailed Description:


I. To conduct a pilot study to inform the design of a mobile health application for smartphone that is targeted to increase physical activity and reduce risks associated with breast cancer.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 22 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Facilitating Motivational Readiness and Adoption of Physical Activity by Breast Cancer Survivors With a Smart Phone Application
Actual Study Start Date : September 2, 2015
Actual Primary Completion Date : August 31, 2016
Actual Study Completion Date : May 17, 2018

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Supportive care (smart phone application)
Participants download the physical activity readiness smart phone application onto their personal smartphone and receive training on how to use the app which includes animated video clips, tailored email reminders, and feedback on progress for 3 weeks.
Device: Smart Phone Monitoring Device
Use activity tracker application
Other Name: Monitor

Primary Outcome Measures :
  1. Features of the mobile application that were most used by participants [ Time Frame: 3 weeks ]
    Descriptive statistics using proportions and 90% confidence intervals will be calculated for various features.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • A participant is only able to participate in one phase, not both phases, of the research study
  • Must have completed breast cancer treatment
  • Those on adjuvant hormonal therapy are allowed to participate in the research study (either phase)

Exclusion Criteria:

  • Those who currently meet the Centers for Disease Control and Prevention (CDC)'s physical activity guidelines
  • Those who do not currently use a smartphone (of any kind)
  • Those who do not read and speak English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03054025

Layout table for location information
United States, Pennsylvania
Sidney Kimmel Cancer Center at Thomas Jefferson University
Philadelphia, Pennsylvania, United States, 19107
Sponsors and Collaborators
Sidney Kimmel Cancer Center at Thomas Jefferson University
Layout table for investigator information
Principal Investigator: Andrea Barsevick, PhD Sidney Kimmel Cancer Center at Thomas Jefferson University
Additional Information:
Layout table for additonal information
Responsible Party: Sidney Kimmel Cancer Center at Thomas Jefferson University Identifier: NCT03054025    
Other Study ID Numbers: 15G.393
First Posted: February 15, 2017    Key Record Dates
Last Update Posted: November 1, 2019
Last Verified: October 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases